N/A
Completed N=63
Adaptability and Resilience in Aging Adults-2
Source: ClinicalTrials.gov NCT04068922 ↗Enrolled (actual)
63
Serious AEs
0.0%
Results posted
Jul 2024
Primary outcomePrimary: Session-level Engagement — 6.3 score on a scale
Summary
Chronic low back pain is a major health concern among older adults and is associated with increased economic, functional, and psychological burden. Resilience has been highlighted as a crucial factor in positive health-related functioning, and a growing body of literature supports the use of resilience-based interventions in chronic pain. Therefore, the goals of this project are to examine the feasibility and acceptability of a resilience intervention for chronic low back pain among older adults.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Session-level Engagement |
6.3 | — |
| PRIMARY Treatment Satisfaction |
3.4 | — |
| PRIMARY Treatment Credibility and Expectancy |
7.7 | — |
| PRIMARY Satisfaction With Intervention Content |
2.9 | — |
| PRIMARY Intervention Commencement Rate |
59 | — |
| PRIMARY Participant Retention |
50 | — |
| PRIMARY Questionnaire Feasibility |
96.8 | — |
| PRIMARY Home Activity Feasibility |
4.6 | — |
Eligibility Criteria
Inclusion Criteria
- Age 60 and older
- Low back pain on at least half the days over the previous 6 months
- Average daily back pain score ≥3 on a 0-10 numerical rating scale
- At least moderate (≥3/10) CLBP-related interference on a 0-10 numerical rating scale
- Able to read/write in English
Exclusion Criteria
- Current participation in another psychological treatment
- Severe psychiatric illness not adequately controlled by medication (e.g., schizophrenia, bipolar disorder) or other conditions anticipated to impair intervention engagement (e.g., substance abuse/dependence)
- Presence of chronic, malignant pain (e.g., HIV, cancer) or systemic inflammatory disease (e.g., rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus, etc.)
- Significant cognitive impairment on the MoCA
- If currently taking prescription analgesic or psychotropic medication, must be stabilized on these treatments for ≥4 weeks prior to the baseline assessment
Data sourced from ClinicalTrials.gov (NCT04068922). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.